查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型和配销通路
市场调查报告书
商品编码
1562394

欧洲肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型和配销通路

Europe Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 78 Pages | 订单完成后即时交付

价格

2022年欧洲肌肉减少症治疗市值为9.9346亿美元，预计2030年将达到14.6781亿美元；预计2022年至2030年复合年增长率为5.0%。

成人营养不良和维生素缺乏症的增加推动了欧洲肌少症治疗市场的发展

营养不良是肌少症的主要危险因子之一。据世界卫生组织称，截至 2021 年，全球约有 23 亿成年人营养不良，占全球人口的近 30%。在已报告的危险因子中，蛋白质能量缺乏是肌少症的常见原因。此外，维生素 D 缺乏或不足与多种疾病的风险增加呈正相关，例如癌症、肥胖、心血管疾病和肌少症。根据美国国立卫生研究院 (NIH) 的数据，全球近 50% 的人口缺乏维生素 D，约 10 亿人缺乏维生素 D。

欧洲少肌症治疗市场概况

欧洲肌少症治疗市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。欧洲在全球肌少症治疗市场中占有重要地位，预计在预测期内复合年增长率显着。

德国因其创新的医疗保健方法而成为一个有吸引力的市场。根据联邦统计局统计，2021年该国的医疗支出达4,740亿美元。肌少症和 SO 在 70 岁及以上的德国男性中相对罕见（<5%）。因此，骨科疾病病例的激增，加上对营养补充剂的需求不断增长，推动了德国肌少症治疗市场的成长。

欧洲少肌症治疗市场收入及 2030 年预测（百万美元）

欧洲肌少症治疗市场区隔

欧洲肌少症治疗市场按治疗类型、配销通路和国家分类。

根据治疗类型，欧洲肌少症治疗市场分为维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等。 2022 年，维生素 D 和钙补充剂细分市场占据欧洲肌肉减少症治疗市场份额最大的份额。

在配销通路方面，欧洲肌少症治疗市场分为药局、零售通路、线上通路等。 2022 年，药局领域占欧洲肌少症治疗市场最大份额。

依国家/地区划分，欧洲肌少症治疗市场分为德国、法国、义大利、英国、西班牙和欧洲其他国家。 2022 年，德国在欧洲肌少症治疗市场份额中占据主导地位。

雅培实验室、安丽公司、拜耳公司、葛兰素史克公司、Metagenics LLC、雀巢健康科学公司、诺华公司、辉瑞公司和赛诺菲公司是欧洲肌少症治疗市场的一些领导公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲少肌症治疗市场 - 主要产业动态

  • 欧洲肌少症治疗市场 - 主要产业动态
  • 市场驱动因素
    • 老年人口激增
    • 成人营养不良和维生素缺乏症增加
  • 主要市场限制：
    • 无法直接干预
  • 主要市场机会：
    • 处于临床试验阶段的产品
  • 未来趋势：
    • 人们对肌少症的认识不断提高
  • 驱动因素和限制的影响：

第 5 章：肌少症治疗市场 - 欧洲市场分析

  • 欧洲肌少症治疗市场收入，2020 - 2030
  • 欧洲肌少症治疗市场预测与分析

第 6 章：欧洲肌肉减少症治疗市场分析 - 依治疗类型

  • 维生素 D 和钙补充剂
  • 蛋白质补充剂
  • 维生素 B12 补充剂
  • 其他的

第 7 章：欧洲肌少症治疗市场分析 - 按配销通路

  • 药局
  • 零售通路
  • 线上通路
  • 其他的

第 8 章：欧洲肌少症治疗市场 - 国家分析

  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 9 章：肌少症治疗市场-产业格局

  • 概述
  • 肌少症治疗市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 10 章：公司简介

  • Abbott Laboratories
  • Bayer AG
  • Metagenics LLC
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc

第 11 章：附录

Product Code: BMIRE00030430

The Europe sarcopenia treatment market was valued at US$ 993.46 million in 2022 and is expected to reach US$ 1,467.81 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030.

Rise in Malnutrition and Vitamin Deficiency Among Adults Boosts Europe Sarcopenia Treatment Market

Malnutrition is one of the major risk factors for sarcopenia. According to the WHO, approximately 2.3 billion adults worldwide were undernourished as of 2021, representing nearly 30% of the global population. Among the reported risk factors, protein-energy deficiency is a frequent cause of sarcopenia. Further, vitamin D deficiency or insufficiency is positively associated with an increased risk of multiple illnesses, such as cancer, obesity, cardiovascular disease, and sarcopenia. According to the National Institutes of Health (NIH), nearly 50% of the world's population suffers from vitamin D insufficiency, and ~1 billion people are vitamin D deficient.

Europe Sarcopenia Treatment Market Overview

The sarcopenia treatment market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global sarcopenia treatment market and is estimated to register a notable CAGR during the forecast period.

Germany is an attractive market due to its innovative approach toward healthcare. According to the Federal Statistical Office, health expenditure in this country amounted to US$ 474 billion in 2021. The awareness of sarcopenia and sarcopenic obesity (SO) is gradually increasing in aging societies across Germany. Sarcopenia and SO are comparatively uncommon (<5%) among German men aged 70 and above. Therefore, an upsurge in the cases of orthopedic disorders, coupled with the rising demand for nutritional supplements, drives the growth of the sarcopenia treatment market in Germany.

Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Sarcopenia Treatment Market Segmentation

The Europe sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the Europe sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Europe sarcopenia treatment market share in 2022.

In terms of distribution channel, the Europe sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Europe sarcopenia treatment market share in 2022.

By country, the Europe sarcopenia treatment market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe sarcopenia treatment market share in 2022.

Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, and Sanofi SA are some of the leading companies operating in the Europe sarcopenia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Sarcopenia Treatment Market - Key Industry Dynamics

  • 4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Upsurge in Geriatric Population
    • 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 4.3 Key Market Restraints:
    • 4.3.1 Unavailability of Direct Interventions
  • 4.4 Key Market Opportunities:
    • 4.4.1 Products in Clinical Trial Phases
  • 4.5 Future Trends:
    • 4.5.1 Rising Awareness About Sarcopenia
  • 4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Europe Market Analysis

  • 5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Europe Sarcopenia Treatment Market Forecast and Analysis

6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type

  • 6.1 Vitamin D and Calcium Supplement
    • 6.1.1 Overview
    • 6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Protein Supplement
    • 6.2.1 Overview
    • 6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Vitamin B12 Supplement
    • 6.3.1 Overview
    • 6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 7.1 Pharmacies
    • 7.1.1 Overview
    • 7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Retail Channels
    • 7.2.1 Overview
    • 7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Online Channels
    • 7.3.1 Overview
    • 7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Sarcopenia Treatment Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Sarcopenia Treatment Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Bayer AG
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Metagenics LLC
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Nestle Health Science SA
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Novartis AG
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Pfizer Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Sanofi SA
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Amway Corp
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 GSK Plc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 21. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
  • Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 22. Growth Strategies in the Sarcopenia Treatment Market